KKR announced addition to Claus Bjerre, KKR Senior Advisor and former Chief Executive Officer of Atos Medical AB and former President, North America, of Coloplast, who will serve as Chairman of Clinisupplies' Board of Directors, and industry veteran Douglas Le Fort, who brings over 20 years of senior executive leadership experience, including as an Executive Committee Member at ConvaTec Group, the Board will be complemented by Oliver Johansen, formerly Senior Vice President, Global Research and Development at Coloplast.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
97.13 USD | +2.11% | +0.37% | +17.24% |
05-02 | Telecom Italia Raises Note Exchange Offers to EUR5.5 Billion Amid Strong Demand | MT |
05-02 | Deutsche Bank Adjusts KKR Price Target to $120 From $122, Maintains Buy Rating | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+17.24% | 84.18B | |
-9.11% | 84.86B | |
+13.22% | 25.63B | |
-6.09% | 17.39B | |
-0.27% | 14.72B | |
+8.20% | 14.28B | |
-22.89% | 11.98B | |
+22.88% | 9.96B | |
+21.54% | 8.68B | |
+21.00% | 7.12B |
- Stock Market
- Equities
- KKR Stock
- News KKR & Co. Inc.
- KKR Appoints Oliver Johansen to the Board of Directors